Abstract
A novel imidazolium derivative (GITag) shows superior ionisation and consequently allows increased mass spectrometric detection capabilities of oligosaccharides and N-glycans. Here we demonstrate that human serum samples can be directly labelled by GITag on a MALDI target plate, abrogating prevalently required sample pretreatment or clean-up steps.
| Original language | English |
|---|---|
| Pages (from-to) | 7003-7006 |
| Number of pages | 4 |
| Journal | Chemical Communications |
| Volume | 57 |
| Issue number | 57 |
| Early online date | 17 Jun 2021 |
| DOIs | |
| Publication status | Published - 21 Jul 2021 |
Bibliographical note
Funding Information:This study was funded by the National Natural Science Foundation of China (NSFC) 31471703, 31671854, 31871793 and 31871754 (to JV and LL), and ERC-COG: 648239 (MCG).
Publisher Copyright:
© The Royal Society of Chemistry 2021.
Research Groups and Themes
- Organic & Biological
Fingerprint
Dive into the research topics of 'Imidazolium labelling permits the sensitive mass-spectrometric detection of N-glycosides directly from serum'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver